The breadth of AI in healthcare applications is broad. How much human oversight is necessary or preferred when leveraging AI in the interest of patient safety?
Listen to this in-depth discussion on how AI can help identify end-to-end data weaknesses, as well as broader implications regarding the inevitability of human interaction.
This is part two of a discussion focused upon data bias, accuracy, access and the future of AI in drug development.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Paul Agapow, Director of Innovation, Data Science and Strategy, GlaxoSmithKline
Mike King, Senior Director of Product and Strategy, IQVIA
Nindhana Paranthaman, Executive Medical Director, Exelixis
Moritz von Stosch, Chief Information Officer, DataHow
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Special Summer Offer: Exclusively on Apple Podcasts, try our Dateline Premium subscription completely free for one month! With Dateline Premium, you get every episode ad-free plus exclusive bonus content.